Webster K - Search Results

1

Development of the Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator (FACT-ICM): A toxicity subscale to measure quality of life in patients with cancer who are treated with ICMs.

Hansen AR, Ala-Leppilampi K, McKillop C, Siu LL, Bedard PL, Abdul Razak AR, Spreafico A, Sridhar SS, Leighl N, Butler MO, Hogg D, Sacher A, Oza AM, Al-Agha R, Maurice C, Chan CT, Shapera S, Feld JJ, Nisenbaum R, Webster K, Cella D, Parsons J. Hansen AR, et al. Among authors: webster k. Cancer. 2020 Apr 1;126(7):1550-1558. doi: 10.1002/cncr.32692. Epub 2020 Jan 8. Cancer. 2020. PMID: 31914209 Free article.

2

Validation of the functional assessment of multiple sclerosis quality of life instrument.

Cella DF, Dineen K, Arnason B, Reder A, Webster KA, karabatsos G, Chang C, Lloyd S, Steward J, Stefoski D. Cella DF, et al. Among authors: webster ka. Neurology. 1996 Jul;47(1):129-39. doi: 10.1212/wnl.47.1.129. Neurology. 1996. PMID: 8710066

3

Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system.

Yellen SB, Cella DF, Webster K, Blendowski C, Kaplan E. Yellen SB, et al. Among authors: webster k. J Pain Symptom Manage. 1997 Feb;13(2):63-74. doi: 10.1016/s0885-3924(96)00274-6. J Pain Symptom Manage. 1997. PMID: 9095563 Free article.

4

Linking outcomes management to quality-of-life measurement.

Cella D, Webster K. Cella D, et al. Among authors: webster k. Oncology (Williston Park). 1997 Nov;11(11A):232-5. Oncology (Williston Park). 1997. PMID: 9430193

5

Missing data in quality of life research in Eastern Cooperative Oncology Group (ECOG) clinical trials: problems and solutions.

Hahn EA, Webster KA, Cella D, Fairclough DL. Hahn EA, et al. Among authors: webster ka. Stat Med. 1998 Mar 15-Apr 15;17(5-7):547-59. doi: 10.1002/(sici)1097-0258(19980315/15)17:5/7<547::aid-sim802>3.0.co;2-f. Stat Med. 1998. PMID: 9549804

6

Quality of life in patients with low-grade non-Hodgkin's lymphoma.

Webster K, Cella D. Webster K, et al. Oncology (Williston Park). 1998 May;12(5):697-714; discussion 714, 717, 721. Oncology (Williston Park). 1998. PMID: 9597680 Review.

7

Using cross-cultural input to adapt the Functional Assessment of Chronic Illness Therapy (FACIT) scales.

Lent L, Hahn E, Eremenco S, Webster K, Cella D. Lent L, et al. Among authors: webster k. Acta Oncol. 1999;38(6):695-702. doi: 10.1080/028418699432842. Acta Oncol. 1999. PMID: 10522759

8

Quality of life and treatment value in the management of hematologic malignancies.

Cella D, Webster KA. Cella D, et al. Among authors: webster ka. Semin Oncol. 1999 Oct;26(5 Suppl 14):34-42. Semin Oncol. 1999. PMID: 10561016

9

Reliability and validity of the functional assessment of cancer therapy-ovarian.

Basen-Engquist K, Bodurka-Bevers D, Fitzgerald MA, Webster K, Cella D, Hu S, Gershenson DM. Basen-Engquist K, et al. Among authors: webster k. J Clin Oncol. 2001 Mar 15;19(6):1809-17. doi: 10.1200/JCO.2001.19.6.1809. J Clin Oncol. 2001. PMID: 11251013

10

Measuring health-related quality of life in patients with hepatobiliary cancers: the functional assessment of cancer therapy-hepatobiliary questionnaire.

Heffernan N, Cella D, Webster K, Odom L, Martone M, Passik S, Bookbinder M, Fong Y, Jarnagin W, Blumgart L. Heffernan N, et al. Among authors: webster k. J Clin Oncol. 2002 May 1;20(9):2229-39. doi: 10.1200/JCO.2002.07.093. J Clin Oncol. 2002. PMID: 11980994

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,119 results

Search Page

Filters